News Center
Current page: Home > News ContentNews Content
All encounters are the reunion after a long separation.On April 12, 2023, the 88th China International Medicine / Intermediates / Packaging / Equipment Fair & The 26th China International Medicine (Industry) Exhibition and Technology Exchange Conference was held in Qingdao World Expo City International Exhibition Center, Shandong Province.
As the flagship exhibition of new products and new technologies in China's pharmaceutical industry, API China & PHARMPACK & SINOPHEX & PHARMEX focus on improving the overall level of production, research and development of Chinese pharmaceutical APIs, intermediates, pharmaceutical packaging materials and pharmaceutical equipment enterprises, and providing safe and healthy drug-using guarantee for the public. This exhibition provides a rare networking opportunity for related industries.
Since its establishment, "Tianjin Minxiang Pharmaceutical" has accumulated and precipitated experience for more than ten years. "Tianjin Minxiang Pharmaceutical" keep exploring and innovating, adhere to the strategic idea of "taking professional scientific research and development as the core, enhancing the comprehensive competitiveness of enterprises", based on product innovation, and carry out technological innovation activities solidly.
.jpg)
At present, "Tianjin Minxiang Pharmaceutical" have the world's leading production of Amantadine Hydrochloride, supporting advanced production line of Amantadine series products, and we are a leading enterprise in the field of Amantadine series products, characteristic pharmaceutical intermediates and characteristic APIs in China.
In March 2023, Tianjin Minxiang Pharmaceutical's Vildagliptin products, have obtained the notice of chemical APIs marketing approval , When Vildagliptin is launched, it will further enrich the company's products and promote the growth of API sales business.
